| DIRECT COMPETITOR COMPARISON | |
| NEOG | IDXX | LIFE | SDIX | Industry | | Market Cap: | 480.14M | 2.98B | 8.91B | 27.10M | 62.33M | | Employees: | 515 | 4,700 | 9,700 | 166 | 56 | | Qtrly Rev Growth (yoy): | 12.30% | 3.20% | 121.40% | 4.40% | 18.90% | | Revenue (ttm): | 122.26M | 1.00B | 2.95B | 27.98M | 12.73M | | Gross Margin (ttm): | 50.63% | 51.15% | 64.07% | 55.57% | 50.63% | | EBITDA (ttm): | 25.73M | 216.89M | 818.22M | -614.00K | -1.76M | | Oper Margins (ttm): | 17.81% | 16.69% | 15.72% | -6.89% | -19.80% | | Net Income (ttm): | 14.54M | 114.83M | 7.87M | -14.07M | N/A | | EPS (ttm): | 0.962 | 1.888 | 0.049 | -0.700 | N/A | | P/E (ttm): | 33.63 | 26.97 | 1019.39 | N/A | 23.64 | | PEG (5 yr expected): | 1.61 | 1.42 | 1.48 | N/A | 1.36 | | P/S (ttm): | 4.02 | 2.97 | 3.08 | 0.92 | 3.09 |
|
| IDXX = IDEXX Laboratories Inc. | | LIFE = Life Technologies Corporation | | SDIX = Strategic Diagnostics Inc. | | Industry = Diagnostic Substances | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.50 | -1.02% | 57.19B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.92 | -1.12% | 13.57B | 15.70 | | Genzyme Corp. | GENZ | 51.07 | -0.87% | 13.55B | 29.12 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.56 | -0.89% | 41.90B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.95 | -1.85% | 8.91B | 1019.39 | | Teva Pharmaceutical Industries Limited | TEVA | 52.88 | -0.53% | 46.59B | 48.38 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 36.96 | -2.25% | 3.92B | 19.05 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.95 | -1.08% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.01 | -1.53% | 5.50B | 110.49 | | Pfizer Inc. | PFE | 18.25 | -1.83% | 147.27B | 15.16 | | Johnson & Johnson | JNJ | 62.89 | -0.65% | 173.52B | 13.73 | | GlaxoSmithKline plc | GSK | 42.26 | -1.45% | 107.13B | 13.42 | | Sanofi-Aventis | SNY | 38.43 | -2.61% | 100.35B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.38 | -0.84% | 125.78B | 16.58 | | RHHBY.PK | 41.46 | -1.96% | N/A | N/A | | AstraZeneca plc | AZN | 45.29 | -2.35% | 65.67B | 9.09 | | Abbott Laboratories | ABT | 54.08 | -0.61% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.38 | -1.05% | 50.28B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | LIFE | | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
Wed, Nov 25 -
GlobeNewswire | | • | SDIX | | STRATEGIC DIAGNOSTICS INC/DE/ Financials
Fri, Nov 20 -
EDGAR Online Financials | | • | LIFE | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Fri, Nov 20 -
Wall Street Transcript | | • | LIFE | | Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
Thu, Nov 19 -
GlobeNewswire | | • | SDIX | | STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly Report
Mon, Nov 16 -
EDGAR Online | | • | LIFE | | LIFE TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities
Fri, Nov 13 -
EDGAR Online | | • | IDXX | | Piper Jaffray Sees Pharma M&A Activity Continuing
Fri, Nov 13 -
Wall Street Transcript | | • | LIFE | | Desktop Bug Detector
Thu, Nov 12 -
at Forbes.com | | • | IDXX | | IDEXX LABORATORIES INC /DE Files SEC form 8-K, Regulation FD Disclosure
Wed, Nov 4 -
EDGAR Online | | • | SDIX | | SmallCapSentinel.com: Records and Revenues
Tue, Nov 3 -
GlobeNewswire | | • | SDIX | | STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Thu, Oct 29 -
EDGAR Online | | • | SDIX | | Strategic Diagnostics Reports Third Quarter 2009 Results
Thu, Oct 29 -
Business Wire | | • | IDXX | | IDEXX LABORATORIES INC /DE Financials
Thu, Oct 29 -
EDGAR Online Financials | | • | IDXX | | Idexx 3Q profit jumps on animal diagnostics sales
Fri, Oct 23 -
AP | | • | IDXX | | Q3 2009 Idexx Laboratories Earnings Release - Before Market Open
Fri, Oct 23 -
CCBN | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
